Clinical Trial Update: A Phase - IIa - IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCD [Phase 2]

View source ↗

Summary

Phase 2 trial examining memantine as a long-term treatment for sickle cell disease to assess safety, tolerability, and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Sickle Cell Disease | Phase 2 | Status: UNKNOWN